Aureus Asset Management, LLC
Source: SEC Form 13F · as of Mar 2026Aureus Asset Management, LLC holds 20 biotech & pharma companies tracked by BioSniper, totaling $91.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$91.8M
| Company | Shares | Value |
|---|---|---|
| ABTABBOTT LABORATORIES | 331,920 | $34.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 125,691 | $34.0M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 8,395 | $3.7M |
| LLYELI LILLY & Co | 4,008 | $3.7M |
| JNJJOHNSON & JOHNSON | 9,841 | $2.4M |
| AMGNAMGEN INC | 5,293 | $1.9M |
| PMPhilip Morris International Inc | 11,235 | $1.9M |
| ABBVAbbVie Inc. | 6,899 | $1.5M |
| UTHRUNITED THERAPEUTICS Corp | 2,500 | $1.5M |
| MRKMerck & Co., Inc. | 11,787 | $1.4M |
| NBIXNEUROCRINE BIOSCIENCES INC | 9,511 | $1.3M |
| NVONovo Nordisk A/S | 27,220 | $1.0M |
| INSMINSMED Inc | 6,000 | $981K |
| NVSNovartis AG | 5,495 | $839K |
| IDXXIDEXX LABORATORIES INC /DE | 713 | $401K |
| GMOptec International, Inc. | 4,125 | $307K |
| ZTSZoetis Inc. | 2,487 | $294K |
| PFEPFIZER INC | 8,423 | $237K |
| BMYBRISTOL MYERS SQUIBB CO | 3,689 | $224K |
| AZNASTRAZENECA PLC | 1,105 | $218K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.